financetom
Business
financetom
/
Business
/
Telo Genomics Receives Accreditation from College of American Pathologists
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Telo Genomics Receives Accreditation from College of American Pathologists
Apr 10, 2024 10:41 AM

01:21 PM EDT, 04/10/2024 (MT Newswires) -- Telo Genomics ( TDSGF ) a biotech company developing a telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncology, on Wednesday said the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to TELO's laboratory at the MaRS Center in Toronto.

The accreditation was awarded after a recent on-site inspection as part of the CAP's Accreditation Programs.

Telo Genomics ( TDSGF ) shares were last seen up C$0.005 to $0.18 on the TSX Venture Exchange.

Price: 0.18, Change: +0.01, Percent Change: +2.86

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved